In vitro Susceptibility of Avian Mycoplasmas to Enrofloxacin, Sarafloxacin, Tylosin, and Oxytetracycline
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
In vitro susceptibility of avian Mycoplasma gallisepticum (MG) and Mycoplasma synoviae (MS) to enrofloxacin, sarafloxacin, tylosin, and oxytetracycline was determined by a serial broth dilution method. The minimum inhibitory concentration (MIC) was recognized by a conversion of the pH indicator phenol red in culture media to a yellow color. Each isolate or type strain of mycoplasma was tested in two replicates. The MICs of tylosin, enrofloxacin, sarafloxacin, and oxytetracycline against five isolates and two reference strains of MG (approximately 10(5) colony-forming units [CFU]/ml) were 0.05, 0.14, 0.37, and 1.30 microg/ml, respectively. The MICs of the four antimicrobial agents against six isolates and one reference strain of MS (approximate 10(5) CFU/ml) were 0.13, 1.82, 1.76, and 0.91 microg/ml, respectively. There were no differences (P > 0.05) between tylosin, enrofloxacin, and sarafloxacin against MG, but these three antibiotics were different (P < 0.05) from oxytetracycline. The MIC value of tylosin against MS was different (P < 0.05) from those of sarafloxacin and enrofloxacin, but it was not different (P > 0.05) from that of oxytetracycline.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, complex therapy, including the sequential use of various drugs and combinations of drugs from different pharmacological groups (example protocol: enrofloxacin therapy for 10-14 days followed by replacement with tylosin), has increasingly demonstrated the best results in practice [64].”
From Mycoplasma Contamination of Primary Cell Cultures (2026) · cites this paper as [64]
Citations
Cites
A medium for the isolation of avian mycoplasmas.
Frey, M. L., Hanson, R. P., & Andrson, D. P. (1968) · PubMed · Cited by 479
Economic Impact of Mycoplasma gallisepticum and M. synoviae in Commercial Layer Flocks
Mohammed, H. O., Carpenter, T. E., & YAMAMOTO, R. S. (1987) · Avian Diseases · doi:10.2307/1590727 · Cited by 155
HANNAN, P. C. T., O’Hanlon, P. J., & ROGERS, N. H. (1989) · Research in Veterinary Science · doi:10.1016/s0034-5288(18)31146-9 · Cited by 104
Whithear, K. G., Bowtell, D. D. L., Ghiocas, E., & Hughes, K. L. (1983) · Avian Diseases · doi:10.2307/1590195 · Cited by 72
Jordan, F. T. W., & Horrocks, B. K. (1996) · Avian Diseases · doi:10.2307/1592228 · Cited by 66
Bradbury, J. M., Yavari, C. A., & Giles, C. (1994) · Avian Pathology · doi:10.1080/03079459408418978 · Cited by 55
Effects of Baytril, Tylosin and Iamulin on avian mycoplasmas
Jordan, F. T. W., Gilbert, S., Knight, D. L., & Yavari, C. A. (1989) · Avian Pathology · doi:10.1080/03079458908418640 · Cited by 51
Jordan, F. T. W., Forrester, C. A., Ripley, P. H., & Burch, D. G. S. (1998) · Avian Diseases · doi:10.2307/1592709 · Cited by 51
Tanner, A. C., & Wu, C.-C. (1992) · Avian Diseases · doi:10.2307/1591770 · Cited by 48
Ley, D. H., Avakian, A. P., & Berkhoff, J. E. (1993) · Avian Diseases · doi:10.2307/1592041 · Cited by 47
Evaluation of Enrofloxacin against Egg Transmission of Mycoplasma gallisepticum
Ortiz, A., Froyman, R., & Kleven, S. H. (1995) · Avian Diseases · doi:10.2307/1592420 · Cited by 26
Kempf, I., Ollivier, C., L'Hospitalier, R., Guittet, M., & Bennejean, G. (1988) · Le Point vétérinaire: revue d'enseignement post-universitaie et de formation permanente · Cited by 9
Problems and opportunities in susceptibility testing of mollicutes
Kenny, G. E. (1996) · Elsevier eBooks · doi:10.1016/b978-012583806-1/50131-0 · Cited by 7
An Epornitic of Mycoplasma gallisepticum in Turkeys
Mason, S. J., & Jd, M. (1984) · Avian Diseases · doi:10.2307/1590245 · Cited by 6
Cited by
Antimicrobial Resistance in Mycoplasma spp
Gautier-Bouchardon, A. V. (2018) · Microbiology Spectrum · doi:10.1128/microbiolspec.arba-0030-2018 · Cited by 207
“Several studies report in vitro susceptibility levels of M. synoviae fi eld isolates (29, 32, 41, 47, 74 – 76, 81, 82) (Table 3).”
BackgroundControl of Avian Mycoplasma Infections in Commercial Poultry
Kleven, S. H. (2008) · Avian Diseases · doi:10.1637/8323-041808-review.1 · Cited by 211
“There are also numerous reports of efficacy testing of various antibiotics in infection models (23,52,57,67,68,106,130,135) and in naturally infected birds (126).”
BackgroundPakpinyo, S., & Sasipreeyajan, J. (2007) · Veterinary Microbiology · doi:10.1016/j.vetmic.2007.05.011 · Cited by 62
Epidemiological study on Mycoplasma synoviae infection in layers
Dufour-Gesbert, F., Dheilly, A., Marois‐Créhan, C., & Kempf, I. (2005) · Veterinary Microbiology · doi:10.1016/j.vetmic.2005.10.040 · Cited by 54
Kreizinger, Z., Grózner, D., Sulyok, K. M., Nilsson, K., Hrivnák, V., Benčina, D., & Gyuranecz, M. (2017) · BMC Veterinary Research · doi:10.1186/s12917-017-1266-2 · Cited by 51
Metadata
- Authors
- Wang, C., Ewing, M., & A'arabi, S. Y.
- Affiliations
- Mississippi State University (US)
- ORCID
- Wang, C.
- Venue
- Avian Diseases
- Publisher
- JSTOR
- Published
- 2001-04
- Volume
- 45
- Issue
- 2
- Pages
- 456
- ISSN
- 0005-2086 (ISSN-L)
- OpenAlex
- W2007440950
- Cited by
- 34
- References
- 14
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 1 · 2020: 3 · 2019: 3 · 2018: 3 · 2017: 3 · 2016: 1 · 2015: 1 · 2013: 3
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Avian Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
- Life Sciences › Immunology and Microbiology › Parasitology › Bird parasitology and diseases
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Keywords
- avian mycoplasma, Mycoplasma gallisepticum, Mycoplasma synoviae, enrofloxacin, sarafloxacin, tylosin, oxytetracycline, antimicrobial susceptibility, minimum inhibitory concentration, poultry
- MeSH terms
- Enrofloxacin, Animals, Anti-Infective Agents, Anti-Bacterial Agents, Cells, Cultured, Ciprofloxacin, Hydrogen-Ion Concentration, Microbial Sensitivity Tests, Mycoplasma, Oxytetracycline, Quinolones, Tylosin, Fluoroquinolones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.